PlumX Metrics
Embed PlumX Metrics

Viability testing to guide myocardial revascularisation in patients with heart failure

Indian Journal of Thoracic and Cardiovascular Surgery, ISSN: 0973-7723, Vol: 34, Issue: Suppl 3, Page: 206-212
2018
  • 3
    Citations
  • 0
    Usage
  • 10
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Review Description

Myocardial revascularisation has the potential to restore ventricular function and improve survival in patients with heart failure due to underlying coronary artery disease. Viability testing is routinely used to identify which patients are likely to benefit, given that revascularisation may entail substantial procedural risk. However, while the concept of viability testing and revascularisation of patients with ‘hibernating myocardium’ is strongly supported by observational series, randomised studies have failed to demonstrate clear benefit. This divergence in the evidence base is reflected in current European and US guidelines, in which viability testing has a class II recommendation. In this article, we review the current evidence for routine viability testing prior to revascularisation of patients with heart failure, outline its use in clinical practice and discuss ongoing trials in the field.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know